Page 1 of 46
123Next ›Last »

2020

Cohen SS, Roger VL, Weston SA, Jiang R, Movva N, Yusuf AA, Chamberlain AM. 2020. Evaluation of claims-based computable phenotypes to identify heart failure patients with preserved ejection fraction. Pharmacol Res Persp (open access).

View Abstract

Dake MD, Fanelli F, Lottes AE, O’Leary EE, Reichert H, Jiang X, Fu W, Iida O, Zen K, Schermerhorn M, Zeller T, Ansel GM. 2020. Prediction model for freedom from TLR from a multi-study analysis of long-term results with the Zilver PTX drug-eluting peripheral stent. Cardiovasc Intervent Radiol, open access.

View Abstract

Eskes C, Corsini E, Hanley V, Karadjova I, Kopp-Schneider A, Suh M, Alves P, Clewell R, Cotgreave I, Navas J, Piersma A, Westmoreland C. 2020. ESAC opinion on the scientific validity of the bioelution test method. In: Viegas Barroso J (ed), EUR 30281 EN. Publications Office of the European Union, Luxembourg, ISBN 978-92-76-20004-8 (online), doi:10.2760/023005 (online), JRC121143.

View Abstract

Cohen SS, Farber-Eger E, Lipworth L, Umejiego J, Dent R, Dluzniewski P, Wells QS. Characteristics and outcomes of a real-world population with heart failure with reduced ejection fraction representative of clinical trial patients. Poster presented to Heart Failure Society of America (HFSA), October 2020.

Elbeddini A, Hooda N, Yang L. 2020. Role of Canadian pharmacists in managing drug shortage concerns amid the COVID-19 pandemic. Canadian Pharmacists J, doi: 10.1177/1715163520929387.

View Abstract

Elbeddini A, Hooda N, Gazarin M, Webster P, McMillan J. 2020. Irinotecan-associated dysarthria in patients with pancreatic cancer: A single site experience. Am J Case Rep, doi: 10.12659/AJCR.924058.

View Abstract

Vago EK, Nicholson G, Horvath-Puho E, Fryzek JP, Su J. Healthcare resource utilization among cold agglutinin disease (CAD) patients in Denmark. Presentation to ISPOR Europe 2020 virtual conference, November 2020.

View Abstract

Fryzek J, Bylsma L, Mease K, Movva N, Welsh BT, Wood M. 2020. Critical insights into nonclinical toxicology and real-world evidence essential for a successful rare disease product launch. EpidStrategies, Inc., white paper.

White Paper

View Abstract

Gage SM, Reichert H. 2020. Determining the incidence of needle-related complications in hemodialysis access: We need a better system. J Vascular Access.

View Abstract

Boice JD, Cohen SS, Mumma MT, Chen H, Golden AP, Beck HL, Till JE. 2020. Mortality among US military participants at eight aboveground nuclear weapons test series. Int J Radiat Biol, doi: 10.1080/09553002.2020.1787543.

View Abstract
Page 1 of 46
123Next ›Last »